Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 1,381 | 1,204 | 1,824 | 2,027 | 2,041 |
| Cost of Goods | 459 | 405 | 575 | 640 | 668 |
| Gross Profit | 921 | 799 | 1,249 | 1,387 | 1,373 |
| Operating Expenses | 3,502 | 1,903 | 2,739 | 2,848 | 2,576 |
| Operating Income | -2,581 | -1,104 | -1,489 | -1,461 | -1,203 |
| Interest Expense | 20 | 43 | 23 | 6 | 2 |
| Other Income | 13 | -6 | 3 | 1,466 | 1,205 |
| Pre-tax Income | -2,588 | -1,152 | -1,510 | N/A | N/A |
| Net Income Continuous | -2,588 | -1,152 | -1,510 | -1,454 | -1,200 |
| Net Income | $-2,588 | $-1,152 | $-1,510 | $-1,454 | $-1,200 |
| EPS Basic Total Ops | -0.03 | -0.02 | -0.03 | -0.04 | -0.03 |
| EPS Basic Continuous Ops | -0.03 | -0.02 | -0.03 | -0.04 | -0.03 |
| EPS Diluted Total Ops | -0.03 | -0.02 | -0.03 | -0.04 | -0.03 |
| EPS Diluted Continuous Ops | -0.03 | -0.02 | -0.03 | -0.04 | -0.03 |
| EBITDA(a) | $-2,485 | $-1,032 | $-1,438 | $-1,405 | $-1,099 |